Abstract
We report the absence of beta-catenin mutations in 63 sporadic colorectal carcinomas (SCRCs) with demonstrated decreased beta-catenin and E-cadherin mRNA expression and E-cadherin protein expression in a subset of carcinomas examined, suggesting that beta-catenin mutations are an extremely rare phenomenon in SCRCs and are not responsible for the transcriptional impairment of the beta-catenin/E-cadherin adhesion complex observed in these tumours.
Publication types
-
Comparative Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adenocarcinoma / genetics*
-
Adenocarcinoma / metabolism
-
Adenocarcinoma / pathology
-
Aged
-
Aged, 80 and over
-
Cadherins / genetics*
-
Cadherins / metabolism
-
Colorectal Neoplasms / genetics*
-
Colorectal Neoplasms / metabolism
-
Colorectal Neoplasms / pathology
-
Cytoskeletal Proteins / genetics*
-
Cytoskeletal Proteins / metabolism
-
DNA, Complementary / genetics
-
DNA, Complementary / metabolism
-
Exons
-
Female
-
Gene Expression Regulation, Neoplastic
-
Gene Rearrangement
-
Humans
-
Immunoenzyme Techniques
-
Male
-
Middle Aged
-
Mutation*
-
Neoplasm Staging
-
Polymerase Chain Reaction
-
Polymorphism, Single-Stranded Conformational
-
RNA, Messenger / metabolism
-
Trans-Activators / genetics*
-
Trans-Activators / metabolism
-
Transcription, Genetic*
-
beta Catenin
Substances
-
CTNNB1 protein, human
-
Cadherins
-
Cytoskeletal Proteins
-
DNA, Complementary
-
RNA, Messenger
-
Trans-Activators
-
beta Catenin